Nonspanning bivalent ligands as improved surface receptor binding inhibitors of the cholera toxin B pentamer

Chemistry and Biology

Volumn 11, Issue 9, 2004, Pages 1205-1215

  Pickens, Jason C ^a   Mitchell, Daniel D ^a,b   Liu, Jiyun ^a   Tan, Xiaojian ^a,b   Zhang, Zhongsheng ^a,b   Verlinde, Christophe L M J ^a,b   Hol, Wim G J ^a,b   Fan, Erkang ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROPHENYLGALACTOSIDE; AMIDE; CELL SURFACE RECEPTOR; CHOLERA TOXIN; LIGAND; PIPERAZINE DERIVATIVE;

AMINO ACID SEQUENCE; ARTICLE; BINDING COMPETITION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; IC 50; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

AMIDES; AMINO ACID SEQUENCE; BINDING, COMPETITIVE; CHOLERA TOXIN; CRYSTALLOGRAPHY, X-RAY; INHIBITORY CONCENTRATION 50; LIGANDS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NITROPHENYLGALACTOSIDES; PIPERAZINES; PROTEIN BINDING; RECEPTORS, CELL SURFACE;

EID: 4644262461     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2004.06.008     Document Type: Article

References (40)

1. Mammen M., Choi S.K., Whitesides G.M. Polyvalent interactions in biological systems. Implications for design and use of multivalent ligands and inhibitors Angew. Chem. (Int. Edit.). 37:1998;2755-2794
2. Kiessling L.L., Strong L.E., Gestwicki J.E. Principles for multivalent ligand design. Annu. Rep. Med. Chem. 35:2000;321-330
3. Hubble J. A model of multivalent ligand-receptor equilibria which explains the effect of multivalent binding inhibitors. Mol. Immunol. 36:1999;13-18
4. Gargano J.M., Ngo T., Kim J.Y., Acheson D.W.K., Lees W.J. Multivalent inhibition of AB(5) toxins. J. Am. Chem. Soc. 123:2001;12909-12910
5. Kitov P.I., Bundle D.R. On the nature of the multivalency effect. a thermodynamic model J. Am. Chem. Soc. 125:2003;16271-16284
6. Burke S.D., Zhao Q., Schuster M.C., Kiessling L.L. Synergistic formation of soluble lectin clusters by a templated multivalent saccharide ligand. J. Am. Chem. Soc. 122:2000;4518-4519
7. Dimick S.M., Powell S.C., McMahon S.A., Moothoo D.N., Naismaith J.H., Toone E.J. On the meaning of affinity. cluster glycoside effects and concanavalin A J. Am. Chem. Soc. 121:1999;10286-10296
8. Wright D., Usher L. Multivalent binding in the design of bioactive compounds. Curr. Org. Chem. 5:2001;1107-1131
9. Pang Y.P., Kollmeyer T.M., Hong F., Lee J.C., Hammond P.I., Haugabouk S.P., Brimijoin S. Rational design of alkylene-linked bis-pyridiniumalidoximes as improved acetylcholinesterase reactivators. Chem. Biol. 10:2003;491-502
10. Wong D.M., Greenblatt H.M., Dvir H., Carlier P.R., Han Y.F., Pang Y.P., Silman I., Sussman J.L. Acetylcholinesterase complexed with bivalent ligands related to huperzine A. experimental evidence for species-dependent protein-ligand complementarity J. Am. Chem. Soc. 125:2003;363-373
11. Han Y.F., Li C.P.L., Chow E., Wang H., Pang Y.P., Carlier P.R. Dual-site binding of bivalent 4-aminopyridine- and 4-aminoquinoline-based aChE inhibitors. contribution of the hydrophobic alkylene tether to monomer and dimer affinities Bioorg. Med. Chem. 7:1999;2569-2575
12. Tamiz A.P., Bandyopadhyay B.C., Zhang J.R., Flippen-Anderson J.L., Zhang M., Wang C.Z., Johnson K.M., Tella S., Kozikowski A.P. Pharmacological and behavioral analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors. J. Med. Chem. 44:2001;1615-1622
13. Abadi A.H., Lankow S., Hoefgen B., Decker M., Kassack M.U., Lehmann J. Dopamine/serotonin receptor ligands, part III. synthesis and biological activities of 7,7′-alkylene-bis-6,7,8,9,14,15-hexahydro-5h-benz D indolo 2,3-g azecines-application of the bivalent ligand approach to a novel type of dopamine receptor antagonist Arch. Pharm. 335:2002;367-373
14. Glick G.D., Toogood P.L., Wiley D.C., Skehel J.J., Knowles J.R. Ligand recognition by influenza virus. the binding of bivalent sialosides J. Biol. Chem. 266:1991;23660-23669
15. Kitov P.I., Shimizu H., Homans S.W., Bundle D.R. Optimization of tether length in nonglycosidically linked bivalent ligands that target sites 2 and 1 of a shiga-like toxin. J. Am. Chem. Soc. 125:2003;3284-3294
16. Lundquist J.J., Debenham S.D., Toone E.J. Multivalency effects in protein-carbohydrate interaction. the binding of the shiga-like toxin 1 binding subunit to multivalent c-linked glycopeptides J. Org. Chem. 65:2000;8245-8250
17. Fan E., Merritt E.A., Verlinde C., Hol W.G.J. AB(5) toxins. structures and inhibitor design Curr. Opin. Struct. Biol. 10:2000;680-686
18. Spangler B.D. Structure and function of cholera toxin and the related escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56:1992;622-647
19. Dewolf M.J.S., Dams E., Dierick W.S.H. Interaction of a cholera-toxin derivative containing a reduced number of receptor-binding sites with intact-cells in culture. Biochimica Et Biophysica Acta-Molecular Cell Research. 1223:1994;296-305
20. Fan E., Zhang Z., Minke W.E., Hou Z., Verlinde C.L.M.J., Hol W.G.J. High affinity pentavalent ligands of escherichia coli heat-labile enterotoxin by modular structure-based design. J. Am. Chem. Soc. 122:2000;2663-2664
21. Merritt E.A., Zhang Z., Pickens J., Ahn M., Hol W., Fan E. Characterization and crystal structure of a high-affinity pentavalent receptor-binding inhibitor for cholera toxin and E. coli heat-labile enterotoxin. J. Am. Chem. Soc. 124:2002;8818-8824
22. Zhang Z.S., Merritt E.A., Ahn M., Roach C., Hou Z., Verlinde C., Hol W.G.J., Fan E. Solution and crystallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin. J. Am. Chem. Soc. 124:2002;12991-12998
23. Minke W.E., Roach C., Hol W., Verlinde C.L. Structure-based exploration of the ganglioside GM1 binding sites of escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists. Biochemistry. 38:1999;5684-5692
24. Pickens J., Merritt E.A., Ahn M., Verlinde C.L., Hol W., Fan E. Anchor-based design of improved receptor-binding antagonists of cholera toxin and escherichia coli heat-labile enterotoxin that display multiple binding modes. Chem. Biol. 9:2002;215-224
25. Mitchell D., Pickens J., Korotkov K., Fan E., Hol W.G.J. 3,5-substituted phenylgalactosides as leads in designing effective cholera toxin antagonists. Synthesis and crystallographic studies Bioorg. Med. Chem. 12:2004;907-920
26. Knoll D., Hermans J. Polymer-protein interactions-comparison of experiment and excluded volume theory. J. Biol. Chem. 258:1983;5710-5715
27. Merritt E.A., Sarfaty S., Feil I.K., Hol W.G.J. Structural foundation for the design of receptor antagonists targeting escherichia coli heat-labile enterotoxin. Structure. 5:1997;1485-1499
28. Merritt E.A., Hol W.G.J. AB(5) toxins. Curr. Opin. Struct. Biol. 5:1995;165-171
29. Mammen M., Dahmann G., Whitesides G.M. Effective inhibitors of hemagglutination by influenza-virus synthesized from polymers having active ester groups-insight into mechanism of inhibition. J. Med. Chem. 38:1995;4179-4190
30. Sigal G.B., Mammen M., Dahmann G., Whitesides G.M. Polyacrylamides bearing pendant α-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus. the strong inhibition reflects enhanced binding through cooperative polyvalent interactions J. Am. Chem. Soc. 118:1996;3789-3800
31. Choi S.K., Mammen M., Whitesides G.M. Generation and in situ evaluation of libraries of poly(acrylic acid) presenting sialosides as side chains as polyvalent inhibitors of influenza-mediated hemagglutination. J. Am. Chem. Soc. 119:1997;4103-4111
32. Merritt E.A., Kuhn P., Sarfaty S., Erbe J.L., Holmes R.K., Hol W.G.J. The 1.25 angstrom resolution refinement of the cholera toxin B-pentamer. evidence of peptide backbone strain at the receptor-binding site J. Mol. Biol. 282:1998;1043-1059
33. Otwinowski Z., Minor W. Processing of x-ray diffraction data collected in oscillation mode. Macromolecular crystallography. 276:1997;307-326
34. Vagin A., Teplyakov A. Molrep. an automated program for molecular replacement J. Appl. Crystallogr. 30:1997;1022-1025
35. Murshudov G.N., Vagin A.A., Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. Sect. D-Biol. Crystallogr. 53:1997;240-255
36. Perrakis A., Morris R., Lamzin V.S. Automated protein model building combined with iterative structure refinement. Nat. Struct. Biol. 6:1999;458-463
37. McRee D.E. Xtalview xfit-a versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125:1999;156-165
38. Vaguine A.A., Richelle J., Wodak S.J. Sfcheck. a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model Acta Crystallogr. Sect. D-Biol. Crystallogr. 55:1999;191-205
39. Hooft R.W.W., Vriend G., Sander C., Abola E.E. Errors in protein structures. Nature. 381:1996;272-272
40. Merritt E.A., Bacon D.J. Raster3d. photorealistic molecular graphics Method. Enzymol. 277:1997;505-524